HKEX: 460
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2026
View original source (HKEXnews)
Earlier from Sihuan Pharmaceutical
- Sihuan Pharmaceutical: VOLUNTARY ANNOUNCEMENT - INSULIN ASPART 30 INJECTION DEVELOPED BY SIHUAN PHARMACEUTICAL ACHIEVED EQUIVALENT CLINICAL RESULTS IN EFFICACY AND SAFETY STUDY AS ORIGINATOR DRUG
- Sihuan Pharmaceutical: VOLUNTARY ANNOUNCEMENT-ENTERING INTO STRATEGIC COOPERATION AGREEMENT BETWEEN JILIN HUISHENG BIOPHARMACEUTICAL AND PORTON PHARMA
- Sihuan Pharmaceutical: VOLUNTARY ANNOUNCEMENT - SHARE REPURCHASE
- Sihuan Pharmaceutical: VOLUNTARY ANNOUNCEMENT-SIHUAN PHARMACEUTICAL OBTAINED DRUG REGISTRATION APPROVAL IN RELATION TO AMBROXOL HYDROCHLORIDE INJECTION